Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls

Area of Science:

• Endocrinology
• Cardiovascular Science
• Lipid Metabolism

Background:

• Oral contraceptives (OCs) are widely used by premenopausal women.
• The impact of low-dose OCs on lipoprotein profiles, particularly LDL subfractions, requires further investigation.
• Altered LDL subfraction profiles are associated with cardiovascular disease risk.

Purpose of the Study:

• To investigate the effect of low-dose oral contraceptives (OCs) on low-density lipoprotein (LDL) subfraction profiles in premenopausal women.
• To compare LDL subfraction patterns between women on OC therapy and those not taking hormonal supplements.

Main Methods:

• Density gradient ultracentrifugation was used to identify and characterize LDL subfraction patterns.
• The relative contribution of light (LDL1), intermediate (LDL2), and dense (LDL3) subfractions to total LDL was quantified.
• Statistical analysis was performed to assess the association between OC use and LDL subfraction patterns, adjusting for lipid and lipoprotein levels.

Main Results:

• OC users exhibited a significantly higher relative contribution of dense LDL3 and a lower contribution of light LDL1 compared to controls.
• OC use was significantly associated with a shift towards a denser LDL subfraction pattern, independent of serum lipid and lipoprotein levels.
• The LDL subfraction distribution in OC users resembled that observed in men.

Conclusions:

• Low-dose oral contraceptives significantly alter LDL composition, promoting a denser LDL subfraction profile.
• This alteration in LDL particle size and density, independent of overall lipid levels, is a potential risk factor for atherosclerosis.
• Further research is warranted to elucidate the long-term cardiovascular implications of OC-induced changes in LDL subfractions.